Effects of small interfering RNA targeting sphingosine kinase-1 gene on the animal model of Alzheimer's disease

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 3, 2013, Pages 427-432

  Zhang, Yuan ^a,b   Yu, Qian ^b   Lai, Tian Bao ^c   Yang, Yang ^a   Li, Gang ^a   Sun, Sheng Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c XIAMEN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; mice; small interfering RNA; sphingolipid metabolism; sphK1 gene

Indexed keywords

PHOSPHOTRANSFERASE; SMALL INTERFERING RNA; SPHINGOSINE KINASE;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; DISEASE MODEL; GENE SILENCING; GENE THERAPY; GENETICS; LEARNING DISORDER; METHODOLOGY; MICROINJECTION; MOUSE; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; TREATMENT OUTCOME;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; GENE SILENCING; GENETIC THERAPY; LEARNING DISORDERS; MICE; MICE, TRANSGENIC; MICROINJECTIONS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RNA, SMALL INTERFERING; TREATMENT OUTCOME;

EID: 84879298113     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1136-5     Document Type: Article

References (26)

1. Selkoe D. The deposition of amyloid proteins in the aging mammalian brain: implications for Alzheimer's disease. Ann Med, 1989,21(2):73-76
2. He X, Huang Y, Li B, et al. Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging 2010,31(3):398-408
3. Walsh DM, Selkoe DJ. Aβ oligomers-a decade of discovery. J Neurochem, 2007,101(5):1172-1184
4. Kirkitadze MD, Bitan G, Teplow DB. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res, 2002,69(5):567-577
5. Shankar GM, Li S, Mehta TH, et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med, 2008,14(8): 837-842
6. Näslund J, Haroutunian V, Mohs R, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA, 2000,283(12): 1571-1577
7. Hannun YA, Obeid LM. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem, 2002,277(29):25847-25850
8. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling. Nat Rev Mol Cell Biol, 2003,4(5): 397-407
9. Bryan L, Kordula T, Spiegel S, et al. Regulation and functions of sphingosine kinases in the brain. Biochim Biophys Acta, 2008,1781(9):459-466
10. Gomez-Brouchet A, Pchejetski D, Brizuela L, et al. Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-beta peptide. Mol Pharmacol, 2007,72(2):341-349
11. Van Brocklyn JR, Jackson CA, Pearl DK, et al. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol, 2005,64(8):695-705
12. Liu H, Sugiura M, Nava VE, et al. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem, 2000,275(26): 19513-19520
13. Spiegel S, Milstien S. Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem, 2007,282(4):2125-2129
14. Anelli V, Gault CR, Cheng AB, et al. Sphingosine kinase 1 is upregulated during hypoxia in U87MG glioma cells: role of hypoxia-inducible factors 1 and 2. J Biol Chem, 2008,283(6):3365-3375
15. Shinpo K, Kikuchi S, Moriwaka F, et al. Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Res, 1999,819(1-2):170-173
16. Kajimoto T, Okada T, Yu H, et al. Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Mol Cell Biol, 2007,27(9):3429-3440
17. Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther, 1998,80(1):35-47
18. Chang KA, Suh YH. Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the β-amyloid precursor protein in Alzheimer's disease. J Pharmacol Sci, 2005,97(4):461-471
19. Zhang YH, Fehrenbacher JC, Vasko MR, et al. Sphingosine-1-phosphate via activation of a G-protein-coupled receptor (s) enhances the excitability of rat sensory neurons. J Neurophysiol, 2006,96(3):1042-1052
20. Patil S, Melrose J, Chan C. Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons. Eur J Neurosci, 2007,26(8):2131-2141
21. Puglielli L, Ellis BC, Saunders, AJ, et al. Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. J Biol Chem, 2003,278(22):19777-19783
22. Tamboli IY, Prager K, Barth E, et al. Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide. J Biol Chem, 2005,280(30):28110-28117
23. Grimm MO, Grimm HS, Pätzold AJ, et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin. Nat Cell Biol, 2005,7(11):1118-1123
24. Palop JJ, Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci, 2010,13(7):812-818
25. Haughey NJ, Bandaru VV, Bae M, et al. Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochim Biophys Acta, 2010, 1801(8):878-886
26. Yu N, Lariosa-Willingham KD, Lin FF, et al. Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes. Glia, 2004,45(1):17-27